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We investigated the neuropathogenic effects of feline immunodeficiency virus (FIV) envelope proteins in the context of both extracellular
exposure and intracellular expression in feline neural cells. The envelope from the neurovirulent CSF-derived FIV V1 strain (V1-CSF) conferred
infectivity to pseudotyped viruses in peripheral blood mononuclear cells (P b 0.01) in contrast to other cell types. Intracellular V1-CSF envelope
expression in macrophages and microglia but not astrocytes resulted in the induction of host inflammatory genes contributing to neurotoxicity
including IL-1β, TNF-α, and indolamine 2′,3′-dioxygenase (IDO) (P b 0.05) with concurrent neuronal death (P b 0.05). Upregulation of the
endoplasmic reticulum stress genes was evident in brains from FIV-infected animals (P b 0.05) and in FIV-infected macrophages (P b 0.05)
relative to controls. Intrastriatal implantation of an FIV envelope pseudotyped virus led to marked neuroinflammation and neuronal injury
associated with neurobehavioral deficits (P b 0.01). Thus, lentivirus envelope proteins exert differential neuropathogenic effects through
mechanisms that depend on the infected or exposed cell type.
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Endoplasmic reticulum stressIntroduction
Lentiviral infections of the nervous system have attracted
increasing attention due to the growing human immunodefi-
ciency virus/acquired immunodeficiency syndrome (HIV/
AIDS) pandemic and the concomitant high rates of neurological
disease among HIV-infected individuals (Manji and Miller,
2004; McArthur et al., 2005). Neurotropism and neurovirulence
are features of all lentiviruses in addition to other retroviruses,
such as specific strains of murine leukemia virus (MuLV)
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doi:10.1016/j.virol.2005.10.044proteins and host immune responses appear to contribute to
lentiviral neuropathogenesis (Anderson et al., 2002; Kaul et al.,
2005; Nath, 2002). The comparative abundance and the
sequences of specific lentivirus gene products or viral strains
influence neurological disease occurrence and severity, as
shown for simian (SIV) (Mankowski et al., 1997), feline (FIV)
(Gruol et al., 1998), and bovine (BIV) (Munro et al., 1998)
immunodeficiency viruses, similar to studies of MuLVs
(Poulsen et al., 1998; Szurek et al., 1990). Indeed, studies of
HIV-associated dementia have shown that viral sequences
isolated from demented patients exert neurovirulent properties
in model systems and may differ from HIV-1 strains from
nondemented patients, particularly within the viral envelope
sequence (Kuiken et al., 1995; van Marle et al., 2002). Both the
HIV-1 surface unit (gp120) and transmembrane unit (gp41)
directly mediate neuronal death in primary neuronal cultures
through NMDA-receptor mediated excitotoxicity (Lipton et al.,
261F. Noorbakhsh et al. / Virology 348 (2006) 260–2761991) and possibly through the engagement of the chemokine
receptors CCR5 and CXCR4 on neurons (Catani et al., 2000;
Mattson et al., 2005; Zheng et al., 1999). In contrast, it has also
been shown that infection of macrophages with brain-derived
HIV-1 strains or recombinant viruses containing brain-derived
HIV envelope sequences leads to the release of soluble
neurotoxic agents in vitro (Gonzalez-Scarano and Martin-
Garcia, 2005; Persidsky and Gendelman, 2003). Hence, the
envelope protein appears to wield both direct and indirect
neuropathogenic effects, culminating in neuronal injury and
death. Parenchymal microglia and perivascular macrophages
are the principal cell types productively infected by lentiviruses
in the brain (Henriksen et al., 1995; Zink et al., 1999). These
cells are exposed to viral structural proteins, i.e., envelope,
through cell surface receptor interactions with subsequent
aberrant signal transduction and also through envelope
synthesis, processing, and transport, which contribute to direct
and indirect neuropathogenic mechanisms, respectively. There
are limited comparative data regarding the effects of lentiviral
envelopes on neuronal survival and host immune responses
when expressed within the neural cells versus extracellular
exposure of the same envelope protein to cell surface receptors.
This issue is relevant given that a major proportion of lentiviral
particles within an infected individual are usually replication
incompetent, yet highly abundant depending on the organ and
stage of disease.
Sharing structural and biochemical properties with HIV-1,
FIV-infected cats have been used as an animal model that
recapitulates many salient aspects of HIV infection including
immunosuppression with depletion of CD4 and CD8 lympho-
cytes in blood and high viral burdens (Podell et al., 1997;
Vitkovic et al., 1995). In fact, FIV also uses chemokine
receptors including CXCR4 and CCR5 for infection although
its cell tropism is broader, and it may use another recently
reported receptor, CD134 (de Parseval et al., 2004; Shimojima
et al., 2004; Willett et al., 1997). Like HIV-1, FIV enters the
central nervous system early in the course of the disease through
infiltrating leukocytes and appears to infect microglia and
perivascular macrophages (Bragg et al., 2002a, 2002b; Dow et
al., 1990). Infected animals show signs of neurological
impairment including ataxia, reduced motor activity, disorien-
tation, as well as psychomotor slowing, aggressiveness and
disrupted sleep and arousal patterns (Henriksen et al., 1995;
Phillips et al., 1994; Steigerwald et al., 1999), all of which are
features of HIV-induced brain disease. In addition to these
similar clinical findings, FIV-infected animals also show similar
neuropathological abnormalities including microgliosis, myelin
pallor, neuroinflammation, altered blood–brain barrier (BBB)
integrity, and neuronal injury and loss (Fox and Phillips, 2002;
Hurtrel et al., 1992; Meeker et al., 1997; Poli et al., 1997). Using
a neonatal feline model, we have previously compared the
neurovirulence of a cerebrospinal (CSF)-isolated FIV strain,
V1-CSF, with the prototype blood-derived Petaluma strain
(Power et al., 1998) and found that the infection with V1-CSF
strain leads to more severe neurodevelopmental abnormalities
and neuropathological changes compared to the Petaluma strain
(Power et al., 1998). By generating an envelope chimera, FIV-Ch, in which the V1-CSF-derived envelope was exchanged for
the corresponding domain in FIV-Petaluma background, we
found that the FIV envelope gene is a major determinant of
neurovirulence (Johnston et al., 2002). However, the compar-
ative pathogenic effects of retrovirus envelope proteins in
different relevant primary neural cells have not been investi-
gated to date. Moreover, many studies have used monomeric
nonglycosylated envelope proteins derived from bacteria for
pathogenesis studies, which may not reflect the effects of the
highly glycosylated trimeric envelopes because of aberrant
protein folding. Hence, we investigated the pathogenic effects
of the FIV-envelope in syngeneically matched primary feline
neural cells. Using pseudotyped viruses and also a neurotropic
Sindbis virus expression system, we compared the infectivity
and syncytia-forming ability of the FIV envelope. We also
explored the consequences of extracellular exposure versus
intracellular expression of the FIVenvelope protein on neuronal
survival and host cellular responses.
Results
In vivo detection of FIV envelope gene expression in brain
Numerous studies have reported productive infection of
brain microglia and infiltrating macrophages by HIV-1,
frequently associated with HIV-1 structural gene expression,
including gag- and env-encoded proteins (Wesselingh and
Thompson, 2001; Williams and Hickey, 2002). However, the
evidence for FIV protein expression in the brain is sparse (Dow
et al., 1992; Steffan et al., 1994). In subcortical white matter, we
detected FIV envelope transcripts by nested RT-PCR in the
brains of FIV-Ch-infected cats (Fig. 1A). Immunocytochemical
staining showed FIVenvelope immunoreactivity in perivascular
and parenchymal cells (Fig. 1C) resembling macrophages and
microglia (Fig. 1C, arrowheads). Indeed, FIV envelope
immunoreactivity was co-localized with the macrophage/
microglial marker Iba-1 in a parenchymal cell (Fig. 1C, insets),
although there was no co-localization detected with the
astrocyte marker, GFAP. Hence, these studies indicated that
FIV productively infected brain cells of monocytoid lineage
with evidence of envelope mRNA and protein expression.
FIV envelope sequences regulate infection of PBMCs by
pseudotyped viruses
To construct viruses that expressed the FIVenvelope and also
contained a reporter gene, we generated pseudotyped virus
particles by transfecting 293T cells with pNL43-Luc-E−R− and
pcDNA3.1FIVenv vectors, containing the entire V1-CSF
envelope sequence. This envelope sequence belongs to the
FIV A2 clade (Fig. 2A) and differs from the prototypic FIV
strain, Petaluma, by approximately 10% at the amino acid level
(Johnston et al., 2002). Following transfection, FIVenv-encoded
surface unit (SU) immunoreactivity (95 kDa) was detectable in
the supernatants of cells co-transfected with the FIVenv vector
(PV-V1) but not pNL43-Luc-E−R− alone (pLUC) (data not
shown). Concomitant HIV-1 p24 measurements in the
Fig. 1. FIV envelope encoded mRNA and protein are detectable in the brains of infected animals. (A) FIV envelope transcripts were detectable in FIV-Ch-infected
animals' brain-derived cDNA, using a nested PCR protocol. Each lane represents a separate animal (B) No immunoreactivity was detectable for the FIV envelope in
control brain sections, (C) whereas perivascular cells (arrowheads) were immunopositive in infected animals brain sections. The insets show the co-localization of
envelope (red) with the macrophage/microglial marker Iba-1 (green). Arrows indicate blood vessel (BV) margins (Original magnification: B and C, 200×; C inset,
400×).
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ng/ml) for both the pseudotyped virus (PV) and pLUC-encoded
virions. The infectivity of the V1-CSF (PV-V1) envelope
pseudotyped virus was examined in feline PBMCs and
lymphocytic (MYA-1) cells (Miyazawa et al., 1989), together
with CrFK cells (Dean et al., 1999; Siebelink et al., 1995) and
human CD4/CCR5 expressing (Hela) cells. A brain-derived
HIV-1 envelope pseudotyped virus (PV-JRFL) (Zhang et al.,
2003b) was used as a control (Fig. 2B), and all infections were
matched by p24 levels in the inocula. The V1-CSF envelope-
pseudotyped virus particles showed infectivity in feline PBMCs,
as detected by luciferase levels in cell lysates (Fig. 2B).
However, the FIVenvelope pseudotyped virus showed minimal
infection in feline lymphocyte cell line (MYA-1) and Crandle
feline kidney cells (CrFK). The PV-JRFL pseudotyped virus
showed infectivity in Hela cells only (Fig. 2C), as predicted
based on receptor preference (Zhang et al., 2001). Thus, these
findings suggested that the FIV envelope pseudotyped virions
were infectious in a cell type-dependent manner.
FIV envelope expression in feline neural cells
Given that V1-CSF is a neurotropic virus, we examined its
envelope expression in relevant neural cells following infection
of the Sindbis vector encoding the FIV envelope. In CD18-
immunopositive feline microglia (Fig. 3A), and GFAP-immu-
nopositive astrocytes (Fig. 3B), SINrep5-EGFP infection showed
EGFP expression in both microglia (Fig. 3C), and astrocytes(Fig. 3D). Similarly, the SINrep5-FIVenv-V1 expressed envelope
proteins in both microglia (Fig. 3E) and astrocytes (Fig. 3F)
although syncytia formation was not observed for either virus in
these cell types. However, SINrep5-FIVenv-V1 infection of
BHK cells exhibited numerous syncytia unlike SINrep5-EGFP
(data not shown). FIV envelope transcript levels in SINrep5-
FIVenv-V1-infected microglia were similar to that of FIV-Ch-
infected cells (Fig. 3G). Infection of astrocytes with the Sindbis
vector led to a much higher level of envelope expression
compared to FIV-Ch-infected astrocytes (Fig. 3H), as expected
based on the limited infection of astrocytes by lentiviruses (Gorry
et al., 2003; Tornatore et al., 1994). The pseudotyped viruses
failed to show any luciferase activity in feline microglia,
astrocytes, or monocyte-derived macrophages, while these
same feline cells infected with vesicular stomatitis virus envelope
pseudotyped viruses showed luciferase activity (data not shown).
Thus, these studies revealed that the Sindbis vector system
permitted detectable FIV envelope protein expression in neural
cells while negligible infection of neural cells occurred with the
pseudotyped viruses.
FIV envelope mediates direct and indirect neuropathogenic
effects
Despite substantial neuronal loss in lentivirus-induced brain
diseases, the number of productively infected neurons is
minimal (Bagasra et al., 1996; Podell et al., 2000; Takahashi et
al., 1996). This consistent observation has led to the assumption
Fig. 2. V1-CSF envelope confers infectivity to pseudotyped viruses. (A) Phylogenetic tree comparing different FIVenvelope sequences. (B) Luciferase assay showed
the infectivity of V1-CSF envelope pseudotyped (PV-V1) and HIV-JRFL envelope pseudotyped (PV-JRFL) viruses. PV-V1 exhibited high infectivity for feline
peripheral blood leukocytes (PBLs). PV-JRFL displayed high infectivity only in Hela cells, as expected based on receptor preference (Tukey–Kramer multiple
comparisons test; *P b 0.05, **P b 0.01, ***P b 0.001).
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molecules causes neuronal injury and death during lentivirus
infections (Bragg et al., 2002a; Nath and Geiger, 1998; Zink et
al., 1999). To explore this concept further using the present
viruses, we examined neuronal death following envelope
expression within and outside of neurons. When applied to
neurons at matched HIV-1 p24 levels, the V1-CSF envelope
pseudotyped virus caused significantly greater neuronal (LAN-
2) death than the control (pLUC-encoded viruses) 24 h post-
infection (Fig. 4A), as detected by trypan blue dye exclusion.
Similarly, the SINrep5-FIVenv-V1 was also more neurotoxic
than the matched SINrep5-EGFP-infected neurons (Fig. 4B). In
both cases, neurons treated with supernatants from mock-
infected cells showed negligible cell death.
To complement these direct neurotoxic findings, we also
examined the effects of supernatants from primary feline neural
cells exposed to the pseudotyped virus or infected with theSindbis clone expressing V1-CSF envelope protein and
corresponding controls. Supernatants from pseudotype-treated
macrophages showed significantly higher levels of cell death
(Fig. 4C) compared to pLUC- or mock-treated macrophages, as
assessed by trypan blue dye exclusion in neuronal (LAN-2) cells
24 h post-exposure. However, supernatants from pseudotype-
treated microglia or astrocytes did not cause significant neuronal
death (Fig. 4C). Conversely, supernatants from both SINrep5-
FIVenv-V1-infected macrophages and microglia were signifi-
cantly more neurotoxic compared to SINrep5-EGFP-derived
supernatants and supernatants from mock-infected cells (Fig.
4D). Astrocyte-derived supernatants following infection did not
show higher neurotoxicity than matched SINrep5-EGFP-
derived supernatants (Fig. 4D). Thus, both FIV envelope
intracellular expression and extracellular exposure in specific
target cells caused release of soluble neurotoxins although
macrophages appeared to mediate greater neurotoxicity. These
Fig. 3. SINrep5-mediated FIVenvelope expression in neural cells. (A) CD18-immunopositive feline microglia and (B) GFAP-immunopositive feline astrocytes were
infected with enhanced green fluorescent protein (EGFP)-expressing SINrep5. EGFP fluorescence was detectable in both (C) microglia and (D) astrocytes 24 h after
infection. Likewise, infection with V1-CSF FIV envelope-expressing SINrep5 led to envelope immunoreactivity in microglia (E) and astrocytes (F) 24 h after
infection. Insets represent envelope immunoreactivity in mock-infected astrocytes (E, lower inset) or microglia (F, lower inset). (G) Infection with the FIV envelope-
expressing SINrep5 or the FIV-Ch virus led to similar levels of envelope expression in feline microglia but (H) in astrocytes, FIV-Ch caused much lower envelope gene
expression (original magnification, 400×).
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whether exposed extracellularly to a neuron or intracellularly to
nascent envelope protein in glial cells.
Intracellular and extracellular exposure to the FIV envelope
have diverse effects on host inflammatory responses
Pathogenic host responses to lentiviral proteins, including the
induction and release of pro-inflammatory molecules including IL-
1β, TNF-α and IDO, have been demonstrated to have importantroles in lentivirus-induced neuroinflammation (Nath et al., 1999;
Persidsky et al., 1997; Sardar and Reynolds, 1995). To explore the
impact of extracellular exposure versus intracellular expression of
the FIVenvelope in terms of inducing prototypic neuropathogenic
host responses in the nervous system, we infected primary feline
macrophages, microglia, or astrocytes with SINrep5-FIVenv-V1
and V1-CSF-pseudotyped (PV-V1) viruses with appropriate
controls in addition to the replication-competent chimeric FIV
clone (FIV-Ch). Feline macrophages were infected with an
MOI = 1.0 of SINrep5-FIVenv-V1 and RNA was extracted 24
Fig. 4. V1-CSF envelope is directly and indirectly cytotoxic to neurons. (A) Extracellular exposure to V1-CSF envelope-containing pseudotyped virions was cytotoxic
to neurons. (B) Intracellular expression of the V1-CSF envelope, by SINrep5 also induced neuronal death. Supernatants of (C) feline macrophages exposed to PV-V1
were neurotoxic, whereas supernatants of PV-V1 exposed microglia (C) and astrocytes manifested minimal neurotoxicity. Supernatants from both feline macrophages
and microglia infected with the V1-CSF envelope expressing SINrep5 virus (D) caused neurotoxic effects, whereas astrocyte-derived supernatants did not show
significant neurotoxicity. Cell death is shown as relative fold increase (RFI ± SEM) compared to mock treatment (Tukey–Kramer multiple comparisons test;
**P b 0.01, **P b 0.001).
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increases in interleukin (IL)-1β (Fig. 5A) and tumor necrosis factor
(TNF)-α (Fig. 5B) mRNA levels compared to SINrep5-EGFP ormock-infected cells. Interestingly, feline macrophages also showed
significant transcriptional upregulation of the neuroinflammation-
associated enzyme, indolamine 2,3-dioxygenase (IDO) (Fig. 5C)
Fig. 5. Intracellular expression and extracellular exposure to the FIVenvelope exert differential effects on macrophage gene expression. Intracellular expression of V1-
CSF envelope by SINrep5-FIVenv-V1 (SIN-Env) in feline macrophages induced IL-1β (A), TNF-α (B), and IDO (C) gene expression, whereas extracellular exposure
led to (D) IL-1β, but not (E) TNF-α or (F) IDO induction. (D) Infection with the FIV-Ch virus caused only IL-1β upregulation. mRNA levels are shown as relative fold
change (RFC ± SEM) compared to mock treatment (Tukey–Kramer multiple comparisons test; *P b 0.05, **P b 0.01).
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typed virus (PV-V1) to macrophages led to induction of IL-1β
mRNA in feline macrophages 24 h post-infection but a greater
inductionwas detected in FIV-Ch-infected cells. (Fig. 5D) although
viruses had no significant effects on TNF-α (Fig. 5E) or IDO (Fig.
5F) mRNA levels.
Similarly, infection of microglia with an MOI = 1.0 of the
SINrep5-FIVenv-V1 virus resulted in increased mRNA levels of
IL-1β (Fig. 6A) and TNF-α (Fig. 6B) but not IDO (Fig. 6C), 24
h post-infection compared to SINrep-EGFP and mock-infected
cultures. Infection of feline microglia with FIV-Ch induced IL-1β
(Fig. 6D), TNF-α (Fig. 6E), and IDO (Fig. 6F)mRNAexpression,
while the pseudotyped virus-, pLUC- and mock-exposed
microglial cultures failed to exhibit any host gene activation.
Infection of astrocytes with an MOI = 1.0 of the SINrep5-
FIVenv-V1 led to the upregulation of IL-1β (Fig. 7A) and IDO
24 h post-infection (Fig. 7C) compared to SINrep5-EGFP ormock-infected cells, although TNF-α mRNA levels (Fig. 7B)
were not induced. Interestingly, exposure of astrocytes to
pseudotyped virus led to the significant upregulation of IL-1β
(Fig. 7D), TNF-α (Fig. 7E), and IDO (Fig. 7F) compared to the
pLUC- or mock-exposed cells. Together, these experiments
showed that the FIV envelope had differential effects on host
neuroimmune responses when expressed inside target cells as
opposed to engaging cell surface receptors, with the intracellular
expression exerting a more potent effect on host inflammatory/
neurotoxic gene expression in macrophages and microglia.
FIV infection induces endoplasmic reticulum stress responses
Induction of endoplasmic reticulum (ER) stress genes due
to accumulation of misfolded proteins in the ER may play a
role in some retrovirus-induced neurodegenerative processes
(Dimcheff et al., 2003; Kim et al., 2004; Liu et al., 2004).
Fig. 6. Intracellular and extracellular exposure to FIVenvelope have differential effects on microglial gene expression. Intracellular expression of the V1-CSF envelope
by SINrep5-FIVenv-V1 (Sin-Env) in feline microglia induced (A) IL-1β and (B) TNF-α but not (C) IDO gene expression. Extracellular exposure did not lead to
induction of (D) IL-1β, (E) TNF-α, or (F) IDO. However, infection with FIV-Ch caused upregulation of all three genes studied. mRNA levels are shown as relative
fold change (RFC ± SEM) compared to mock treatment (Tukey–Kramer multiple comparisons test; *P b 0.05, **P b 0.01).
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endoplasmic reticulum (ER)-associated stress responses accom-
pany infection of the brain (Dimcheff et al., 2003; Kim et al.,
2005; Liu et al., 2004). In fact, very recent studies indicate the
magnitude of the ER stress response was dependent on the
individual envelope sequence and the specific ER-associated
gene (Dimcheff et al., 2004). To investigate this issue in the
context of FIV infection and envelope expression, we analyzed
the comparative expression of three ER chaperones in feline
macrophages because they exhibited the most vigorous
neurotoxic and immune responses, following infection with
different viruses containing the FIVenvelope (Fig. 8). The genes
examined included PERK, a protein kinase involved in the
attenuation of protein translation during ER stress, Grp58/
ERp57, and BiP (Grp78). Gene expression studies with the RNA
extracted 24 h post-infection revealed that while infection by the
V1-CSF envelope pseudotyped virus and pLUC failed to induce
expression of PERK, Grp58, and BiP, FIV-Ch infection inducedboth of the former genes in feline macrophages (Fig. 8A).
Conversely, macrophages infected with the SINrep5-FIVenv-
V1, SINrep5-EGFP, or mock-infected cells did not show any
differential increase or suppression of the above ER-associated
stress genes 24 h post-infection relative to controls (data not
shown). Indeed, no induction of ER stress genes was observed in
microglia nor astrocytes following infection with any of the
above viruses including SINrep5-FIVenv-V1, pseudotyped
viruses or FIV-Ch relative to their respective controls (data not
shown). However, PERK, Grp58, and BiP were induced in the
brains of FIV-Ch-infected animals compared to mock-infected
controls (Fig. 8B). Immunofluorescence studies of the brains of
FIV-Ch-infected animals showed that the immunoreactivity of
PERK was co-localized with CD18 leukocyte/macrophage
marker in white matter (Fig. 8C, left column). Likewise,
Grp58 (Fig. 8C, middle column) and BiP (Fig. 8C, right
column) immunoreactivity in white matter was co-localizedwith
the macrophage/microglial marker Iba-1. Immunoreactivity for
Fig. 7. Both intra- and extracellular FIVenvelope exposures induce astrocytic inflammatory gene expression. Intracellular expression of the V1-CSF envelope in feline
astrocytes induced (A) IL-1β and (C) IDO but not (B) TNF-α gene expression. Extracellular exposure of the pseudotyped virus was able to induce (D) IL-1β, (E) TNF-
α, and (F) IDO mRNA levels. mRNA levels are shown as relative fold change (RFC ± SEM) compared to mock treatment (Tukey–Kramer multiple comparisons test;
*P b 0.05, **P b 0.01).
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both mock- and FIV-infected animals (data not shown). These
studies suggested that V1-CSF envelope expression at either the
cell surface or intracellularly in relevant cells was insufficient for
induction of ER stress genes, while infection by the replication
competent V1-CSF envelope-containing chimeric FIV (in a
Petaluma molecular background) upregulated specific ER stress
genes. Likewise FIV-Ch infection also induced ER stress genes
in the brain tissue of FIV-infected animals.
FIV envelope pseudotyped virus is neurovirulent in vivo
Many studies have shown that monomeric nonglycosylated
lentiviral envelope proteins have neuropathogenic effects when
introduced into rodent species. However, it remains unclear if
mere exposure of heavily glycosylated trimeric lentiviral
envelope proteins can exert deleterious effects when introduced
into their natural hosts. Since the V1-CSF envelope-pseudo-
typed virus expressed a functional envelope protein and was
neurotoxic in vitro, we next examined its ability to inducedisease in vivo employing neuropathological and neurobeha-
vioral parameters previously used for assessment of HIV-1
mediated neuropathogenesis (Zhang et al., 2003a). Implantation
of the striatum was performed because this anatomical region of
the brain exhibits high densities of monocytoid cells in the brain
together with being particularly vulnerable to the adverse effects
of lentivirus infections (reviewed in Gonzalez-Scarano and
Martin-Garcia, 2005). Implantation with the nonpseudotyped,
pLUC-encoded viruses resulted in minimal activation of
astrocytes (Fig. 9A) and microglia (Fig. 9B), together with
negligible neuronal injury and loss (Fig. 9C) in the vicinity of
the implantation lesions (L). Conversely, implantation of the
V1-CSF envelope-pseudotyped viruses (PV-V1) caused robust
astrocytic and microglial activation, as evidenced by numerous
hypertrophied GFAP-immunopositive astrocytes (Fig. 9D) and
Iba-1-immunopositive microglia (Fig. 9E), proximal to the
needle track lesions (L). Indeed, PV-V1 virus also caused
neuronal loss, detected by diminished neuronal nuclei antigen
(NeuN) immunoreactivity (Fig. 9F) near the lesion site (L). At 3
days post-infection, there were no neurobehavioral differences
Fig. 8. ER stress genes are induced by FIV infection in vivo and in vitro. (A) Infection of feline macrophages with FIV-Ch led to PERK and Grp58 induction while
pseudotyped virus exposure did not influence ER stress gene expression. (B) Brains of animals infected with the FIV-Ch virus show upregulation of PERK, Grp58 and
BiP. mRNA levels are shown as relative fold change (RFC ± SEM) compared to mock treatment. (C) Double labeling showed the co-localization of PERK with CD18
leukocyte/microglial marker in the brains of FIV-Ch-infected animals. Likewise, Grp58 and BiP immunoreactivity was co-localized with Iba-1 (macrophage/
microglial) immunoreactivity (Student's t test and Tukey–Kramer multiple comparisons test; *P b 0.05, original magnification: 400×).
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significantly higher mean ipsiversive rotary behaviors were
observed in PV-V1 injected animals, indicative of more severe
neurological injury (Fig. 9G). Thus, these observations confirm
our in vitro data (Fig. 4), suggesting a neurotoxic role for the V1
envelope-pseudotyped virus in the context of FIV-induced
neuroinflammation.
Discussion
The purpose of the present study was to compare the
pathogenic effects of a lentivirus envelope protein presented
intra- or extracellularly in relevant primary neural cells. Using
the V1-CSF envelope pseudotyped virus and the Sindbis virus
expression systems, both extracellular exposure and intracel-
lular expression of the V1-CSF envelope protein exerted
cytotoxic effects on neurons (summarized in Table 1). In
addition, intracellular expression of the envelope in macro-
phages and microglia led to the production of soluble
neurotoxic factors by these cells with a concomitant induction
in host neuroimmune genes including IL-1β, TNF-α, and IDO,whereas only macrophages released soluble neurotoxins when
exposed to the pseudotyped virus. Although intracellular
expression of the FIV envelope seemed to be a more potent
activator of host neuroimmune gene expression in macro-
phages and microglia, the pseudotyped virus and hence
extracellular envelope exposure was more effective in inducing
the expression of inflammatory mediators in astrocytes, which
are usually nonproductively infected during the course of
lentivirus infections (Table 1). FIV replication competence was
necessary for induction of ER stress responses, indicating a
possible role for protein misfolding processes in FIV
neuropathogenesis that was not limited to the envelope
protein. In vivo intrastriatal implantation of the FIV envelope
pseudotyped virus led to significant neuronal loss, astrocytosis,
and microglial reaction, associated with neurobehavioral
changes in the implanted animals, indicating that extracellular
exposure alone of the envelope protein was sufficient for the
development of neuropathogenic effects.
Previous studies have reported that HIV-1 envelope can
induce apoptosis in primary neurons by a mechanism
involving ERK and JNK MAP kinase activation (Lannuzel
Fig. 9. V1-CSF envelope pseudotyped virus is neurotoxic in vivo. Intrastriatal implantation of pLUC-containing supernatant did not cause astrocytic (A) or microglial
(B) reaction or neuronal loss (C). Conversely, implantation of V1-CSF envelope pseudotyped virus (PV-V1) caused severe astrocytosis (B), microglial reaction (D),
and neuronal loss (F) as detected by GFAP, Iba-1 and NeuN immunoreactivities, respectively. The lesion caused by injection is marked as “L”. Insets show a higher
magnification of the same field for GFAP-reactive astrocytes (D, inset) or Iba-1-reactive microglia (B and E, inset) in the corresponding animal. Neurological damage,
assessed at days 3 and 7 in animals receiving intrastriatal implants of either PV-V1 or pLUC supernatants, revealed that PV-V1 implanted animals showed higher
percent of ipsiversive rotations 7 days after implantation (G), indicative of a more severe neurobehavioral deficit (Student t test; **P b 0.01, original magnification:
200×, inset: 400×).
270 F. Noorbakhsh et al. / Virology 348 (2006) 260–276et al., 1997). Moreover, the neurotoxicity of brain-derived
JRFL envelope pseudotyped viruses is reduced by treatment of
neurons with anti-CCR5 and CXCR4 monoclonal antibodies
and also G-protein-mediated signaling inhibitor, pertussis
toxin (Zhang et al., 2003b). These findings underscore the
importance of cell surface receptor signaling in envelope-
mediated neurotoxicity. However, the retroviral envelope
protein synthesis and processing also activate different cell
stress mechanisms. Recently, it has been shown that a
neurovirulent MuLV prolonged chaperone binding and
retention of the envelope protein in the endoplasmic reticulum
(ER), resulting in activation of ER stress proteins with
potential pathogenic actions (Dimcheff et al., 2004; Kim et
al., 2004). The HIV-1 envelope is also known to interact with
ER molecular chaperones including BiP and calreticulin as
part of its processing and subsequent folding in the ER (Earl etal., 1991; Otteken and Moss, 1996). Here, we show that
infection with replication-competent FIV-Ch caused the
induction of ER stress genes PERK and Grp58 in vitro. In
addition, the chaperone molecule Grp78/BiP, a monitor of
endoplasmic reticulum stress (Lee, 2005), was upregulated in
the brains of infected animals. A variety of physiological and
pathological conditions can lead to the induction of ER
chaperones (reviewed in Lee, 2001). While ER stress proteins
(i.e., Grp78/BiP) can be induced in the brain tissue during
embryonic development, injurious stimuli including ischemia,
trauma, and seizures have also been shown to induce ER
chaperones in adult rodent brain tissue (Little et al., 1996).
This can exert a neuroprotective response against stress-
induced neuronal death through refolding or facilitating the
proteasomal degradation of misfolded proteins, as reported for
some neurodegenerative disorders (Hetz et al., 2005; Jin et al.,
Table 1
Summary of neurotoxicity and inflammatory/ER stress gene expression for different cell types after FIV envelope expression/exposure or infection with replication-
competent virus
Target cell Intracellular envelope expression Extracellular envelope exposure Replication competent FIV infection
Neurotoxicity Inflammatory/ER stress
gene expression
Neurotoxicity Inflammatory/ER stress
gene expression
Neurotoxicity Inflammatory/ER stress
gene expression
Macrophages ++ IL-1β, TNF-α, IDO,
no ER stress
+++ IL-1β, no ER stress ++ a, b IL-1β, PERK, Grp58 c
Microglia +++ IL-1β, TNF-α, no ER stress − None, no ER stress + b IL-1β, TNF-α, IDO,
no ER stress
Astrocytes − IL-1β, IDO, no ER stress − IL-1β, TNF-α, IDO,
no ER stress
NDd None, no ER stress
Neurons +++ ND ++ ND ND ND
a Johnston et al., 2002.
b Power et al., 1998.
c PERK, Grp58 and BiP were induced in vivo in the brains of FIV-Ch-infected animals.
d ND—not done.
271F. Noorbakhsh et al. / Virology 348 (2006) 260–2762000; Katayama et al., 1999). However, it has also been
reported that ER overload by some viral proteins can lead to
the activation of transcription factor NF kappa B (Pahl et al.,
1996; Waris et al., 2002), which in turn can play a key role in
mounting an immune response. Whereas this could constitute
a primitive antiviral response linked to viral gene expression,
it can also contribute to immune-mediated neuronal injury in
the context of lentivirus-induced neuroinflammation.
The presence of neuronal injury and death during the course
of lentiviral brain infection, together with the apparent lack of
direct neuronal infection has prompted substantial research
efforts focused on characterizing the neurotoxic agents
produced by microglia, infiltrating macrophages and astrocytes
(Kaul et al., 2001; Nath and Geiger, 1998). With several
inflammatory cytokines, chemokines, and matrix metallopro-
teinases previously identified, we now show that the tryptophan
catabolizing enzyme indolamine 2,3-dioxygenase (IDO) can be
induced in macrophages and astrocytes following FIVenvelope
exposure. IDO has diverse immunosuppressive properties,
through both degradation of tryptophan, an essential amino
acid required for cell proliferation, and also the downstream
kynurenine derivatives' effects, both neuroprotective (kynur-
enine) and neurotoxic (quinolinic acid). IDO has also been
shown to play a role in the pathogenesis of lentiviral
encephalopathy, with its activity increased in the frontal cortex
brain tissue of patients suffering from HIV dementia (Sardar
and Reynolds, 1995). Moreover, brain-derived HIV-1 isolates
are capable of inducing IDO synthesis and subsequent
kynurenine metabolism in primary human macrophages
(Grant et al., 2000). IDO biosynthesis is also upregulated in
the brains of rhesus monkeys infected with simian immunode-
ficiency virus (SIV), and its levels are correlated with viral
burden and diminished after antiretroviral treatment (Burudi et
al., 2002). Herein, we show that intracellular expression of FIV
envelope induces IDO expression in feline macrophages. Of
interest, both intra- and extracellular exposure to envelope also
activates IDO transcription in feline astrocytes. Thus, there may
be a direct link between specific lentiviral envelope sequences
and their neurovirulence with their ability to activate the
kynurenine metabolism pathway.Despite previous studies showing that HIV-1 envelope
exposure to and expression in human astrocytes leads to
induction of host genes implicated in lentivirus neuropatho-
genesis (van Marle et al., 2004) with the concomitant
secretion of neurotoxic molecules (van Marle et al., 2003),
the present studies in astrocytes did not yield similar findings.
Nevertheless, both intracellular expression and extracellular
exposure of feline astrocytes to FIV envelope resulted in an
induction of host neuroimmune responses without an
accompanying release of neurotoxins (Table 1). This
discordance may reflect the individual virus system, the use
of adult-derived astrocytes as opposed to fetal astrocytes and
astrocytic cell lines used for HIV-1 studies or the present use
of a human neuronal cell line as a target cell (Richardson et
al., 1989). In addition, there were several examples herein in
which host immune genes were activated without accompa-
nying matched supernatant-derived neurotoxicity, underscor-
ing the complex relationship between immune responses
generated by glial cells and neuronal survival (Nakajima and
Kohsaka, 2004; Piehl and Lidman, 2001).
Due to the high rate of error-prone reverse transcription
among lentiviruses, most of a lentiviral quasispecies within an
infected individual is comprised of replication-incompetent
viruses (Engelman et al., 1995; Fisher et al., 2002).
Nonetheless, we identified marked astrocytosis, microgliosis,
and neuronal loss after intrastriatal injection of replication-
incompetent FIV envelope-pseudotyped viruses. The current in
vivo observations in a lentivirus' natural host extend earlier
studies showing in vitro neurotoxic properties of an HIV-1
envelope pseudotyped virus (Zhang et al., 2003b) and direct in
vitro effects of lentivirus envelope proteins (Aggoun-Zouaoui
et al., 1996; Bennett et al., 1995; Lannuzel et al., 1995;
Ushijima et al., 1995). Moreover, the present findings
emphasize the point that in vivo replication competence is
not the sole requisite feature of neurovirulence. However, the
nature of the interaction of the lentivirus envelope with the
neuronal cell surface receptor(s) remains uncertain, given that
the lentivirus surface unit requires formation of a trimer for
infectivity but apparently not for in vitro direct neurotoxicity
(Lipton et al., 1991). Future studies will require further
272 F. Noorbakhsh et al. / Virology 348 (2006) 260–276delineation of the in vivo and in vitro interactions between the
lentivirus envelope proteins and host cytosolic molecules
together with clearer definition of the envelope protein
interaction with neuronal surface proteins leading diminished
neuronal survival.
Materials and methods
Cell lines and infectious viruses
293T cells (American Type Culture Collection) and HeLa-
CD4/CXCR4/CCR5 cells were cultured in Dulbecco modified
Eagle medium containing 10% fetal bovine serum (FBS) and a
1% penicillin–streptomycin solution (Gibco BRL) (Zhang et
al., 2003b). The feline lymphocyte cell line (MYA-1) and
Crandle feline kidney cells (CrFK) were obtained from ATCC
and grown according to supplier's instructions. Feline astrocyte
and microglial cultures were prepared using 8- to 10-week-old
animal brain tissue as previously described (Giuliani et al.,
2003). Feline peripheral blood mononuclear cells (PBMCs)
were purified from FIV seronegative animals blood with
Histopaque (Sigma) and maintained in RPMI 1640 medium
with 10% FBS (Power et al., 1998) and from which monocyte
derived-macrophages were prepared, as previously reported
(Johnston and Power, 1999). For all primary feline cell cultures,
at least two donors were used to avoid donor-specific effects. As
there are no feline neuronal cell lines available, we used human
cholinergic neuronal (LAN-2) cells maintained in minimum
essential medium containing 10% FBS, 1% penicillin–strepto-
mycin solution, and 1% N2 supplement (Gibco BRL) and then
differentiated for 2 days in Leibovitz's L-15 medium (Gibco
BRL), containing 1mM of dibutyryl-cyclic AMP, 10% FBS and
50 μg of gentamicin per milliliter (Silva et al., 2003). The
recombinant neurovirulent FIV strain, FIV-Ch was cultured and
titered as previously described (Power et al., 1998). Super-
natants of mock-transfected feline PBMCs were used to infect
the animals in the control group.
Construction of pSINrep5 and pcDNA3.1 vectors
The Sindbis vector expression system used in this study has
been described previously (van Marle et al., 2003). The
envelope sequence of the neurovirulent FIV strain, V1-CSF
was amplified from a chimeric molecular clone (FIV-Ch)
(Johnston et al., 2002). The following primers were used to
amplify the envelope sequence from both molecular clones
(base position 6237 to 8836); forward primer: 5′-GCT CTA
GAA GAT TAA TAT TTC ATT TGC AAC A-3′, reverse
primer: 5′-CTA GTC TAG ATC ATT CCT CCT CTT TTT
CAG ACA T-3′. Fragments were purified from gel using
QIAGEN gel extraction kit and cloned into the XbaI site of
pSINrep5 multiple cloning site. Construction of pSINrep5-
EGFP has been reported previously (van Marle et al., 2003).
The PCR-amplified FIV envelope sequence was also cloned
into the pcDNA3.1 XbaI restriction site (pcDNA3.1FIVenv).
For all constructs, correct insertion of the inserts was
determined by restriction enzyme digest analysis and sequenc-ing. All restriction enzymes were obtained from New England
Biolabs (Mississauga, ON) or Life Technologies and used
according to their instructions. In addition, the V1-CSF and
other FIV envelope sequences were compared phylogenetically
using DNASTAR with the analysis rooted to PLV14 (van Marle
et al., 2003).
Production of SINrep5-FIVenv virus stocks
To produce the virus stocks capable of transducing cells,
pSINrep5-FIVenv and pSINrep5-EGFP and helper virus
construct pDH-BB were linearized with XhoI. The linearized
plasmids were used as templates for the generation of capped
RNA transcripts by in vitro run-off transcription using the SP6
mMESSAGE mMACHINE kit (Ambion Inc., Austin, TX). 10
μg of DH-BB RNA transcript and 10 μg of SINrep5-FIVenv or
SINrep5-EGFP RNA transcript were transfected to 3–5 × 106
BHK-21 cells/ml in PBS by electroporation according to a
previously published protocol (van Marle et al., 2003). Briefly,
the cells were subjected to two pulses at 850 V, 50 μF, and ∞Ω,
using a Gene Pulser II (Bio-Rad Laboratories Canada Ltd.,
Missisauga, ON). Cells were plated in culture media and
incubated at 37 °C/5% CO2. The media containing the
recombinant SINrep5 viruses were harvested 20–24 h after
transfection. Recombinant SINrep5 stocks were titered in BHK
cells, as previously reported (van Marle et al., 2003). For
SINrep5-FIVenv, cells were immunostained using a monoclonal
antibody directed against the FIV envelope (National Institutes
of Health AIDS Research and Reference Reagent Program,
Catalog Number: 4820), and the number of FIV envelope-
positive cells was counted. For SINrep5-EGFP, the titer was
determined by counting the number of EGFP-positive cells
using fluorescent microscopy at 24 h post-infection, which has
been shown to be the optimal time-point for Sindbis vector-
mediated gene expression (van Marle et al., 2003).
Pseudotyped virus generation and infection assay
To produce pseudotyped virus particles, HEK 293T cells
plated in 6-well plates were co-transfected with pcDNA3.1FI-
Venv containing the FIV V1-CSF envelope with a plasmid
expressing firefly luciferase within an env-inactivated HIV-1
clone (pNL43-Luc-E−R−), using Fugene6 according to manu-
facturer's instructions (Roche Applied Sciences). Co-transfec-
tion with pNL43-Luc-E−R− and an empty pcDNA3.1 vector
was performed as a control. The HIV-1 p24 core antigen levels
released in the supernatants of transfected 293T cells were
measured with the HIV-1 p24 Antigen Capture Assay Kit
(AIDS Vaccine Program, National Cancer Institute, Frederick,
MD), in accordance with the manufacturer's instructions and
used to match viral inputs (80 ng/ml). Western blot analysis of
supernatants from transfected cells was performed to detect FIV
envelope using an anti-FIV envelope monoclonal antibody
(National Institutes of Health AIDS Research and Reference
Reagent Program). Infection of target cells by pseudotyped
virus led to expression of luciferase, which was quantified in
cell lysates 2 days following virus addition with the Luciferase
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typed supernatant-treated cells as controls. In addition, the
supernatants containing the infectious chimeric molecular clone
(FIV-Ch) in which the V1-CSF envelope was encoded within a
Petaluma background (34TF10) were used for infection of
cultured cells at an input titer of 104 TCID50/ml, as previously
reported (Johnston et al., 2000).
In vitro direct and indirect neurotoxicity assays
For assaying direct neurotoxicity, LAN-2 neuronal cells
seeded in 96-well plates were infected with SINrep5 virus
constructs (MOI = 1) or the pseudotyped virus-containing
supernatants from transfected 293T cells. The levels of cell
death were assessed by trypan blue dye exclusion 24 h after
infection. For analyses of indirect neurotoxicity, feline micro-
glia and astrocytes were infected with SINrep5 clones
(MOI = 1) or the pseudotyped virus-containing supernatants.
After 4 h, the inoculating supernatants were replaced by AIM-V
media after washing cells with fresh media. At 20 h,
supernatants were collected and applied to differentiated
human neuronal (LAN-2) cells in serum-free AIM-V medium
(Gibco BRL). Cell death was assessed by trypan blue dye
exclusion and subsequent counting at 24 h post-application. All
neurotoxicity experiments were done in triplicate. Cell death
was expressed as relative fold increase (RFI) in trypan blue
positive cells compared to background cell death in untreated
neuronal cultures.
Real-time RT-PCR
Brain tissue (left frontal lobe) from 12-week control and FIV-
Ch-infected animals (Johnston et al., 2002) and cultured cells
were homogenized and lysed in TRIzol (Invitrogen) according
to the manufacturer's guidelines. Total RNA was isolated and
dissolved in diethylpyrocarbonate (DEPC)-treated water, and 1
μg of RNAwas used for the synthesis of complementary DNA
and PCR reactions as described previously (Power et al., 2003).
A nested PCR protocol was used to amplify FIV envelope from
brain-derived cDNA. First-round PCR consisted of 40-cycle
amplification using the following primers to obtain a 386-bp
PCR product; forward primer: 5′-TGG AAT AAC AGA AAA
AGA AAA-3′; reverse primer 1: 5′-GGA AGT CTC CATACT
ACC TGA-3′. Second-round PCR consisted of 40-cycle
amplification using the same forward primer and the reverse
primer 2: 5′-AAC GCA TGA ACC AGG GAC AAT-3′ to
obtain a 173-bp PCR product. Primers sequences for host gene
expression studies were as follows: GAPDH, forward primer:
5′-AGC CTT CTC CAT GGT GGT GAA GAC-3′, reverse
primer: 5′-CGG AGT CAA CGG ATT TGG TCG-3′; IL-1β,
forward primer: 5′-CCA AAG AAG AAG ATG GAA AAG
CG-3′, reverse primer: 5′-GGT GCT GAT GTA CCA GTT
GGG-3′; TNF-α, forward primer: 5′-CCC CAG GGC TCC
AGA AGG T-3′, reverse primer: 5′-TGG GGC AGA GGG
TTG ATT AGT TG-3′; indolamine-2′,3′-deoxygenase forward
primer: 5′-GGC AAA CTG GAA GAA AAA AGG-3′, reverse
primer: 5′-ATT TCC ACC AATAGA GAG AC-3′. Sequencesfor PERK, Grp58 and BiP primers have been reported
previously (Dimcheff et al., 2003). Semiquantitative analysis
was performed by monitoring in real time the increase of
fluorescence of the SYBR Green dye on a Bio-Rad i-Cycler, as
previously reported (Power et al., 2003) and expressed as
relative fold change (RFC) compared to mock-infected cultures.
Immunofluorescence and immunocytochemistry
Paraffin-embedded sections (5 μm) of cat brain tissue were
deparaffinized and hydrated using decreasing concentrations of
ethanol. Antigen retrieval was performed by boiling sections in
0.01 M citrate buffer, pH 6.0, for 10 min. Endogenous
peroxidases were inactivated by incubating sections in 0.3%
hydrogen peroxide for 20 min. To prevent nonspecific binding,
sections were preincubated with 10% normal goat serum for 1
h at room temperature. To detect neurons, astrocytes, and
macrophages/microglia, primary antibodies to neuronal nuclear
antigen (anti-NeuN) (Chemicon International) (1/200), glial
fibrillary acidic protein (anti-GFAP) (DAKO, Copenhagen,
Denmark) (1/200), and ionized calcium binding adaptor
molecule 1 (Iba-1) (1/500); diluted in PBS/0.2% Triton X-
100/5% serum were used respectively. Appropriate secondary
biotinylated antibodies followed by avidin–biotin–peroxidase
application (Vector Laboratories) were used subsequently. FIV
envelope expression was detected by a monoclonal antibody
directed against the FIV envelope surface unit (National
Institutes of Health AIDS Research and Reference Reagent
Program, catalogue number: 4820) followed by an Alexa488- or
Cy3-conjugated goat–antimouse secondary antibody (Molecu-
lar Probes, Eugene, Oregon, USA). Similarly, the identities of
primary cultured cell types were confirmed by immunofluores-
cence using antibodies to feline CD18 (obtained from Dr. Peter
Moore, UC Davis) and GFAP, as described above. All
immunocytochemical and immunofluorescent stainings includ-
ed controls without primary antibodies to ensure specificity of
binding. Slides were examined on an Olympus Fluoview
(FV300) confocal laser scanning microscope.
Stereotactic implantations and neurobehavioral studies
Ten-week-old specific pathogen free cats, obtained from the
University of Calgary Animal Research Centre, were used for
this experiment. Animals were placed in a stereotaxic frame
under ketamine/xylazine anesthesia. Each animal received two
implants of supernatants (10 μl) containing nonpseudotyped
pLUC-encoded viruses (n = 4) or V1-CSF envelope
pseudotyped viruses (n = 4) from transfected 293T cells into
the right striatum (5 mm posterior, 5 and 6 mm lateral, 5 mm
deep relative to bregma), matched for viral input based on HIV
p24 levels (80 ng/ml). In vivo neurological injury was assessed
according to the Ungerstedt model (Johnston et al., 2001; Silva
et al., 2003; Ungerstedt and Arbuthnott, 1970). In short,
ipsiversive rotations as well as the total number of rotations
were monitored over 10 min after i.p. injection of amphet-
amine (1 mg/kg) on days 3 and 7 following striatal
implantation with more ipsiversive rotations being indicative
274 F. Noorbakhsh et al. / Virology 348 (2006) 260–276of neurological injury. Animals were sacrificed after 7 days,
and brain sections proximal to the site of implantation were
prepared for immunohistochemical analyses. All experiments
were approved by the University of Calgary Animal Care
Committee.
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